Latest California Healthline Stories
La tasa de personas sin seguro médico se mantiene estable, a pesar de la purga de Medicaid
Aproximadamente el 8% de los estadounidenses no tuvieron cobertura en 2023, un aumento estadísticamente insignificante de solo 0.1 puntos porcentuales con respecto al año anterior.
ACA Enrollment Platforms Suspended Over Alleged Foreign Access to Consumer Data
Federal regulators provided more specifics about why they suspended two private sector Affordable Care Act enrollment sites, including concerns about potential overseas accessing of consumer data and suspicions of involvement in Obamacare enrollment and switching schemes. The companies reject the assertions.
Longtime Head of L.A. Care To Retire After Navigating Major Medi-Cal Changes
John Baackes, who steered Medi-Cal’s largest health plan following the Affordable Care Act expansion, and later prepared it for a state overhaul of Medi-Cal, will retire after this year. Baackes believes low payments to doctors and other providers, along with an acute labor shortage, hamper Medi-Cal’s success.
Errors in Deloitte-Run Medicaid Systems Can Cost Millions and Take Years To Fix
As states wait for Deloitte to make fixes in computer systems, Medicaid beneficiaries risk losing access to health care and food.
Feds Killed Plan To Curb Medicare Advantage Overbilling After Industry Opposition
A private 2014 decision by the Centers for Medicare & Medicaid Services faces new scrutiny in a multibillion-dollar Justice Department fraud case against UnitedHealth Group.
An Arm and a Leg: Don’t Get ‘Bullied’ Into Paying What You Don’t Owe
In this episode of “An Arm and a Leg,” host Dan Weissmann speaks with Caitlyn Mai, a woman in Oklahoma who received a six-figure bill for a surgery her insurance promised to cover. This episode is an extended version of the “Bill of the Month” series, produced in partnership with NPR.
Her Life Was at Risk. She Needed an Abortion. Insurance Refused To Pay.
Insurance coverage for abortion care in the U.S. is a hodgepodge. Patients often don’t know when or if a procedure or abortion pills are covered, and the proliferation of abortion bans has exacerbated the confusion.
For Pharma, Trump vs. Harris Is a Showdown Between Two Industry Foes
Vice President Kamala Harris is seen as more aggressive than former President Donald Trump in taking on pharmaceutical companies, but Trump allies say he would also make lowering drug costs a top priority.
Cuando la aseguradora se niega a pagar un aborto que es médicamente necesario
En el país, la cobertura para la atención del aborto es laberíntica. A menudo, los pacientes no saben cuándo un procedimiento, o las píldoras abortivas, están cubiertas, si es que lo están; y la proliferación de prohibiciones ha exacerbado la confusión.
Para las farmacéuticas, la pelea entre Trump y Harris es entre dos enemigos de la industria
Legisladores de ambos partidos atacan cada vez más a la industria, por los precios de los medicamentos que la mayoría de los estadounidenses consideran irrazonables.